A MUSC trial at 22 primary care practices found Moodivate users had twice the depression reduction of usual care and were 2.3 times likelier to reach remission.
Trial findings from MUSC
The Medical University of South Carolina reports that a trial at 22 MUSC primary care practices examined patients using the Moodivate behavioral activation app. According to the Medical University of South Carolina, patients using the app saw depression reductions that were twice those seen with usual care. The source describes Moodivate as a behavioral activation app.
The Medical University of South Carolina says the reported results came from a primary care trial involving patients at the 22 MUSC practices. The source compares the app users’ results with usual care, rather than reporting an outcome for Moodivate users alone. The extract does not provide individual patient results.
Remission finding
The Medical University of South Carolina also reports that Moodivate users were 2.3 times more likely to reach remission than patients receiving usual care. The source presents remission as a separate result alongside the reported difference in depression reductions.
The Medical University of South Carolina’s extract does not state how many patients participated in the trial or give a remission percentage for either group. It also does not describe the length of app use, the details of usual care, or which patients may have been included in the trial.
Published study
According to the Medical University of South Carolina, the trial was published in JAMA Internal Medicine. The source identifies the setting as 22 MUSC primary care practices and describes the intervention as the Moodivate behavioral activation app.
The reported findings are specific to the trial described by the Medical University of South Carolina. The source extract reports comparative results between app users and usual care, including the two-fold difference in depression reduction and the 2.3-times higher likelihood of remission.
What this means for South Carolina patients
For people seeking to find treatment locally, the directory lists 35 published clinics in South Carolina. The MUSC report describes a primary-care app trial and its reported depression and remission findings.
This is general information, not medical advice.
More South Carolina reporting on treatment updates.
This report is educational and is not medical advice. Coverage, availability and eligibility can change; verify details with the named source or your care team.